Shire (SHPG) Announces Receipt of FDA Breakthrough Therapy Designation for SHP621, SHP625
Tweet Send to a Friend
Shire plc (Nasdaq: SHPG) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for two ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE